Loading...
Hims & Hers Health, Inc.
HIMS•NYSE
Consumer Defensive
Household & Personal Products
$41.98
$-22.25(-34.64%)
Hims & Hers Health, Inc. (HIMS) Financial Performance & Statements
Review Hims & Hers Health, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
69.33%
↑ 69.33%
Operating Income Growth
310.18%
↑ 310.18%
Net Income Growth
635.28%
↑ 635.28%
Operating Cash Flow Growth
241.69%
↑ 241.69%
Operating Margin
6.16%
↑ 6.16%
Gross Margin
77.04%
↑ 77.04%
Net Profit Margin
9.21%
↑ 9.21%
ROE
35.97%
↑ 35.97%
ROIC
17.98%
↑ 17.98%
Hims & Hers Health, Inc. (HIMS) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Hims & Hers Health, Inc. stock.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $481.14M | $401.56M | $315.65M | $278.17M |
Cost of Revenue | $111.60M | $83.67M | $100.49M | $49.08M |
Gross Profit | $369.54M | $317.89M | $215.16M | $229.09M |
Gross Profit Ratio | $0.77 | $0.79 | $0.68 | $0.82 |
R&D Expenses | $23.75M | $21.09M | $18.65M | $15.32M |
SG&A Expenses | $269.11M | $226.90M | $184.85M | $165.12M |
Operating Expenses | $350.94M | $295.51M | $203.50M | $219.19M |
Total Costs & Expenses | $404.46M | $378.32M | $303.99M | $268.27M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $6.06M | $4.38M | $3.64M | $3.001M |
EBITDA | $24.66M | $26.76M | $14.67M | $12.90M |
EBITDA Ratio | $0.05 | $0.07 | $0.05 | $0.05 |
Operating Income | $18.60M | $22.37M | $11.66M | $9.90M |
Operating Income Ratio | $0.04 | $0.06 | $0.04 | $0.04 |
Other Income/Expenses (Net) | $3.69M | $1.22M | $2.39M | $2.50M |
Income Before Tax | $22.29M | $23.59M | $13.42M | $12.40M |
Income Before Tax Ratio | $0.05 | $0.06 | $0.04 | $0.04 |
Income Tax Expense | -$3.73M | -$51.99M | $127000.00 | $1.27M |
Net Income | $26.02M | $75.59M | $13.30M | $11.13M |
Net Income Ratio | $0.05 | $0.19 | $0.04 | $0.04 |
EPS | $0.12 | $0.35 | $0.06 | $0.05 |
Diluted EPS | $0.11 | $0.32 | $0.06 | $0.05 |
Weighted Avg Shares Outstanding | $219.03M | $216.62M | $214.62M | $213.45M |
Weighted Avg Shares Outstanding (Diluted) | $240.73M | $235.07M | $234.79M | $229.36M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan